Nicolas Andre Castellano

Nicolas Castellano practices at Nazareth Hospital in Philadelphia, Pennsylvania, part of Trinity Health.

Nicolas Castellano's NPI, 1215194337, was assigned on May 16, 2008. Nicolas Castellano holds District of Columbia license MD036869.

Nicolas Castellano's primary practice is Nazareth Hospital, at 2601 Holme Ave, Philadelphia, PA 19152 in Philadelphia County. The practice phone is (215) 335-6000.

Nicolas Castellano's primary practice is Nazareth Hospital in Philadelphia, Pennsylvania, part of Trinity Health. Nicolas Castellano is also affiliated with Bayhealth Hospital, Kent Campus. The medical group on file is Critical Care Physicians of Pennsylvania. Dmand AI also links Nicolas Castellano to 7 more hospitals, 9 medical groups and 1 skilled nursing facility, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Nicolas Castellano practices, 10 sites in all. Vendor and product names are available with a free account.

Internal medicine is Nicolas Castellano's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Nicolas Castellano is licensed in District of Columbia.

CMS data shows 448 Medicare services from Nicolas Castellano across 2 procedure codes in 2024, for 225 Medicare patients. Medicare paid $73,768 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 225 Medicare patients who saw Nicolas Castellano in 2024. The largest group is 65 to 74, with 78 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 48% are also on Medicaid. Their average risk score is 3.31, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Nicolas Castellano's median patient age at 71, with 51% women.

Nicolas Castellano accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Nicolas Castellano as offering telehealth.

CMS Open Payments shows 5 general payments to Nicolas Castellano from 2 drug and device companies from 2018 to 2019. Consulting fees make up the largest share, 70% of the total. Merck Sharp & Dohme Corporation paid the most, $150.